Clinical trials are multifaceted activities comprising Clinical Research Organisations, Phase 1 Units/Hospitals/outpatient settings, Patients, Clinical Laboratories and Specialist laboratories all working in tandem to move new drug entities through the drug development and approvals process.
Agilex Biolabs is the largest regulated bioanalytical laboratory in Australia with over 24 years’ experience in early phase clinical trials with a track record of enabling the movement of new drug entities to market. Agilex Biolabs specialises in pharmacokinetics, pharmacodynamics, and biomarker evaluation, which is key to understanding the drug absorption, distribution, metabolism, and excretion as well as target engagement and efficacy of the drug during clinical development.
Choosing the right bioanalytical platform for your immunology or vaccines clinical trial is critical to data collection. But navigating the intricate bioanalytical process and selection of assay platforms can be difficult. What do these platforms look like in use, and how should you go about selecting the right one?
This webinar will demystify the bioanalytical requirements for clinical studies and will discuss the most common bioanalytical platforms used during clinical trials to measure vaccine responses and levels of inflammatory mediators in biological fluids.
Key Learning Objectives
- Learn how to determine the right bioanalytical platform for your immunology or vaccines clinical trial
- Understand what do these bioanalytical platforms look like in use
- Understand the process of selecting the right bioanalytical platform
- Demystify the bioanalytical requirements for clinical studies